QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=DF855E1FCDC082CA178D4759DE591992;jsessionid=CEC07D6E3BD976C0A49BA3484965CE27;jsessionid=CC2B2FF77BE70ED30A59008DC57D82D7;jsessionid=E63805CABAD71175734E9B2289B44B50;jsessionid=1153749D79E22E0098E6695EFC5B19D4;jsessionid=2010E9D70E7F2B50B62D0ABF56187104;jsessionid=8B9B96DC58D7DDF4855EF8231F0A5687;jsessionid=FFA657FB24ED889F42AAA4FD2CDDAF19;jsessionid=8FB108FE9457260572E0CB931D2D8AC6 (gene)

No studies found

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=DF855E1FCDC082CA178D4759DE591992;jsessionid=CEC07D6E3BD976C0A49BA3484965CE27;jsessionid=CC2B2FF77BE70ED30A59008DC57D82D7;jsessionid=E63805CABAD71175734E9B2289B44B50;jsessionid=1153749D79E22E0098E6695EFC5B19D4;jsessionid=2010E9D70E7F2B50B62D0ABF56187104;jsessionid=8B9B96DC58D7DDF4855EF8231F0A5687;jsessionid=FFA657FB24ED889F42AAA4FD2CDDAF19;jsessionid=8FB108FE9457260572E0CB931D2D8AC6